MiniMed Group, Inc. Common Stock
NASDAQ:MMEDMedical - Care Facilities
+$0.40 today
- Market cap
- $4.78B
- Beta
- -3.63
- P/E (TTM)
- -14.2
- EPS (TTM)
- -$1.91
Volume 4.70M
Average 0.95M
MMED Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
MiniMed Group, Inc. Common StockNASDAQ: MMED
Cost of Revenue · Q1 FY2026 · quarter ended Jul 2026
Cost of revenue of $378M in Q1 FY2026
Q1 FY2026 cost of revenue was $378M. Trailing-twelve-month cost of revenue was $1.49B. Over 3 fiscal years it compounded at +14.9% a year.
Context
- Cost of revenue amounted to 45.8% of revenue in FY2025, up 2.0 pp from a year earlier.
- Cost of revenue increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly cost of revenue holds near $378M or moves back toward the trailing-twelve-month quarterly average of $371.75M.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 1.42B USD
- Year-over-year change
- +19.5%
- 3-year CAGR
- +14.9%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2026-04-24 | 1.42B | +19.5% |
| FY2024 | 2025-04-30 | 1.19B | +15.3% |
| FY2023 | 2024-04-30 | 1.03B | +10.1% |
| FY2022 | 2023-04-30 | 937M | — |
Cost of Revenue vs competitors
How MMED compares with its peers on the latest reported figures
- MMED's LTM Jul 2026 cost of revenue of $1.49B is the 3rd highest of the 7 companies compared; the peer median is $673.12M.
- Cost of revenue amounts to 46.2% of revenue for MMED, versus a peer median of 40.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jul 2026 | $12.51B | +0.0% | +5.9% | 33.3% | |
| LTM Jun 2026 | $1.86B | +5.2% | +21.9% | 37.5% | |
MMEDMiniMed Group, Inc. Common Stock | LTM Jul 2026 | $1.49B | — | +14.9% | 46.2% |
| LTM Jun 2026 | $883.1M | +27.9% | +15.4% | 28.9% | |
| LTM Mar 2026 | $463.14M | -21.4% | +7.6% | 45.1% | |
| LTM Mar 2026 | $47.24M | +46.8% | — | 42.8% | |
| LTM Mar 2026 | $19.51M | -11.2% | +12.6% | 47.9% | |
MMEDVMiniMed Group, Inc. | — | — | — | — | — |
| Peer median (excluding MMED) | $673.12M | +2.6% | +12.6% | 40.2% | |
Competitors are the stored peer set for MMED. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Apr 2023 | FY2023 Apr 2024 | FY2024 Apr 2025 | FY2025 Apr 2026 |
|---|---|---|---|---|
| Revenue | 2.25B | 2.47B | 2.72B | 3.1B |
| Cost of Revenue | 937M | 1.03B | 1.19B | 1.42B |
| Gross Profit | 1.31B | 1.44B | 1.53B | 1.68B |
| Gross Margin | 58.3% | 58.2% | 56.2% | 54.2% |
| Research & Development | 429M | 437M | 438M | 448M |
| Selling, General & Admin | 960M | 1.06B | 1.13B | 1.18B |
| Operating Expenses | 1.38B | 1.51B | 1.73B | 1.63B |
| Depreciation & Amortization | 115M | 129M | 143M | 156M |
| EBITDA | 39M | 59M | 107M | 205M |
| EBITDA Margin | 1.7% | 2.4% | 3.9% | 6.6% |
| Operating Income | (69M) | (69M) | (202M) | 49M |
| Operating Margin | -3.1% | -2.8% | -7.4% | 1.6% |
| Interest Income | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (7M) | (1M) | (1M) | (236M) |
| Income Before Tax | (76M) | (70M) | (203M) | (187M) |
| Pre-Tax Margin | -3.4% | -2.8% | -7.5% | -6.0% |
| Income Tax Expense | 16M | 38M | 48M | 128M |
| Net Income | (96M) | (112M) | (250M) | (331M) |
| Net Margin | -4.3% | -4.5% | -9.2% | -10.7% |
| EPS (Basic) | (0.34) | (0.40) | (0.89) | (1.29) |
| EPS (Diluted) | (0.34) | (0.40) | (0.89) | (1.29) |
| Weighted Avg Shares | 280.81M | 280.81M | 280.81M | 256.6M |
| Weighted Avg Shares (Diluted) | 280.81M | 280.81M | 280.81M | 256.6M |
MiniMed Group, Inc. Common Stock
NASDAQ:MMED
Intrinsic Alpha fair value
Locked
Current Price
$16.99
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.